U.K.-based Oxford VR hopes to lead the way in automated VR therapy in the future, and it just raised £10 million ($13.05 million) to help achieve that goal.
The company, which span out of Oxford University’s Department of Psychiatry in 2017, raised the money in a Series A round of funding led by Optum Ventures. According to a press release, the new funds will “enable Oxford VR to accelerate US expansion of its evidence-based and scalable automated VR therapy solution and to continue to expand its treatment pipeline.”
Unlock premium content and VIP community perks with GB M A X! Join now to enjoy our free and premium perks.
Join now →
Sign in to your account.